Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) therapy in over 25,000 patients with CNS malignancies treated between 2011-2022. - Mrugala MM; Shi W; Iwomoto F; Lukas RV; Palmer JD; Suh JH; Glas M (Journal of neuro-oncology, 2024)